Clinical trial
Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome
NCT00159510 · Northern State Medical University, Other · Terminated
Key facts
| NCT number | NCT00159510 |
|---|---|
| Title | Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome |
| Official title | A Controlled Prospective Randomized Open-Label Study of Methylene Blue and Inhaled Nitric Oxide in Patients With Septic Shock and Acute Lung Injury |
| Acronym | MB-NO |
| Lead sponsor | Northern State Medical University, Other |
| Collaborators | Helse Nord Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sepsis |
| Intervention type | Drug |
| Interventions | Methylene blue, Nitric oxide, Methylene blue & nitric oxide |
| Enrollment | 28 |
| Start date | Apr 1, 2004 |
| Primary completion | Sep 1, 2014 |
| Completion | Sep 1, 2014 |
| First posted | Sep 12, 2005 |
| Last update posted | Oct 6, 2015 |
| Countries | Russia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: